Pilot Study of Pembrolizumab Combined With Pemetrexed or Abemaciclib for High Grade Glioma

NCT04220892 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped One of the study drugs will no longer be supplied by manufacturer and the pembrolizumab + abemaciclib study arm is removed due to toxicity seen in other trials.

Conditions

High Grade Glioma

Interventions

DRUG: Pembrolizumab
DRUG: Pemetrexed
DRUG: Abemaciclib

Sponsor

Jose Carrillo

Collaborators

[object Object]